Central cholinergic systems and the P3 evoked potential
- 1 January 1987
- journal article
- research article
- Published by Taylor & Francis in International Journal of Neuroscience
- Vol. 33 (3-4) , 199-205
- https://doi.org/10.3109/00207458708987404
Abstract
A cognitive evoked potential, the P3, is commonly altered in dementia states but little is known of the specific neuronal generators that are the source of this potential. Event-related evoked potentials and neuropsychological testing were obtained in six normal subjects during neuropharmacological manipulation of the central cholinergic system. Scopolamine (an anticholinergic) impaired recent memory, prolonged P3 latency and decreased P3 amplitude. These abnormalities were partially reversed by physostigmine (an anticholinesterase). The results imply that the cholinergic system is involved in the generation of the P3 potential.Keywords
This publication has 23 references indexed in Scilit:
- Effects of oral scopolamine on human stimulus evaluationPsychopharmacology, 1985
- The neurochemistry of Alzheimer's disease and senile dementiaMedicinal Research Reviews, 1983
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- Apomorphine and Other Dopaminomimetics: Basic Pharmacology, Vol. IAmerican Journal of Psychiatry, 1982
- Reversal of Diazepam-induced Postanesthetic Somnolence with PhysostigmineAnesthesiology, 1979
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979
- Event-related Brain Potentials: A Tool in the Study of Human Information ProcessingPublished by Springer Nature ,1979
- COGNITIVE PSYCHOPHYSIOLOGY: THE ENDOGENOUS COMPONENTS OF THE ERPPublished by Elsevier ,1978
- Evaluating storage, retention, and retrieval in disordered memory and learningNeurology, 1974
- The Cholinergic Synapse and the Site of MemoryScience, 1971